De novo cardiomyocytes from within the activated adult heart after injury.
A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable source of stem/progenitor cells that could contribute new muscle after ischaemic heart disease and acute myocardial infarction. A therapeutic ideal--relative to cell transplantation--would be to stimul...
Prif Awduron: | Smart, N, Bollini, S, Dubé, K, Vieira, J, Zhou, B, Davidson, S, Yellon, D, Riegler, J, Price, A, Lythgoe, M, Pu, W, Riley, P |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2011
|
Eitemau Tebyg
-
Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart.
gan: Smart, N, et al.
Cyhoeddwyd: (2012) -
Resident cardiac progenitor cells: at the heart of regeneration.
gan: Bollini, S, et al.
Cyhoeddwyd: (2011) -
Re-activated adult epicardial progenitor cells are a heterogeneous population molecularly distinct from their embryonic counterparts.
gan: Bollini, S, et al.
Cyhoeddwyd: (2014) -
An essential role for thymosin beta 4 in regulating vascular smooth muscle cell development and adult vessel stability
gan: Smart, N, et al.
Cyhoeddwyd: (2012) -
Amniotic fluid stem cells are cardioprotective following acute myocardial infarction.
gan: Bollini, S, et al.
Cyhoeddwyd: (2011)